{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T10:45:05Z","timestamp":1772793905061,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1995,7,1]],"date-time":"1995-07-01T00:00:00Z","timestamp":804556800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother. Pharmacol."],"published-print":{"date-parts":[[1995,7]]},"DOI":"10.1007\/bf00689445","type":"journal-article","created":{"date-parts":[[2004,11,28]],"date-time":"2004-11-28T13:39:16Z","timestamp":1101649156000},"page":"278-282","source":"Crossref","is-referenced-by-count":38,"title":["Possible cardiac side effects of granisetron, an antiemetic agent, in patients with bone and soft-tissue sarcomas receiving cytotoxic chemotherapy"],"prefix":"10.1007","volume":"35","author":[{"given":"Hideomi","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Shinozaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Arita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Chigira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[1995,7,1]]},"reference":[{"key":"BF00689445_CR1","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1200\/JCO.1990.8.2.337","volume":"8","author":"M Addelman","year":"1990","unstructured":"Addelman M, Erlichman C, Fine S, Warr D, Murray C (1990) Phase I\/II trial of granisetron: a novel 5-hydroxytryptamine antagonist for the prevention of chemotherapy-induced nausea and vomiting. J Clin Oncol 8:337\u2013341","journal-title":"J Clin Oncol"},{"key":"BF00689445_CR2","first-page":"187","volume":"382","author":"PLR Andrews","year":"1986","unstructured":"Andrews PLR, Davis CJ, Grahame-Smith DG, and Leslie RA (1986) Increase in3H-2-deoxyglucose uptake in the ferret area postrema produced by apomorphine administration or electrical stimulation of the abdominal vagus. J Physiol., (Lond) 382: 187","journal-title":"J Physiol., (Lond)"},{"key":"BF00689445_CR3","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/0165-6147(88)90106-X","volume":"9","author":"PLR Andrews","year":"1988","unstructured":"Andrews PLR, Rapeport WG, Sanger GJ (1988) Neuropharmacology of emesis induced by anti-cancer therapy. Trends Pharmacol Sci 9: 334\u2013341","journal-title":"Trends Pharmacol Sci"},{"issue":"Suppl 1","key":"BF00689445_CR4","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/0959-8049(92)90628-F","volume":"28A","author":"PLR Andrews","year":"1992","unstructured":"Andrews PLR, Bhandari P, Davey PT, Bingham S, Marr HE, Blower PR (1992) Are all 5-HT3 receptor antagonists the same? Eur J Cancer 28A [Suppl 1]: S2-S6.","journal-title":"Eur J Cancer"},{"key":"BF00689445_CR5","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1002\/1097-0142(19900601)65:11<2539::AID-CNCR2820651125>3.0.CO;2-M","volume":"65","author":"G Bacci","year":"1990","unstructured":"Bacci G, Picci P, Ruggieri P, Mercuri M, Avella M, Capanna R, Brach Del Prever A, Mancini A, Gherlinzoni F, Padovani G, Leonessa C, Biagini R, Ferraro A, Ferruzzi A, Cazzola A, Manfrini M, Campanacci M (1990) Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities. Cancer 65: 2539\u20132553","journal-title":"Cancer"},{"key":"BF00689445_CR6","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0277-5379(83)90418-2","volume":"19","author":"A Coates","year":"1983","unstructured":"Coates A, Abraham S, Kaye SB, Sowerbutts T, Frewin C, Fox RM Tattersall MHN (1983) On the receiving end\u2014patient perception of the side-effects of cancer chemotherapy. Eur J Cancer Clin Oncol, 19: 203\u2013208","journal-title":"Eur J Cancer Clin Oncol"},{"key":"BF00689445_CR7","first-page":"503","volume":"341","author":"P Elliott","year":"1990","unstructured":"Elliott P, Seemungal BM, Wallis DI (1990) Antagonism of the effects of 5-hydroxytryptamine on the rabbit isolated vagus nerve by BRL 43694 and metoclopramide. Naunyn-Schmiedeberg's Arch Pharmacol 341: 503\u2013509","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"BF00689445_CR8","first-page":"335","volume":"91","author":"CS Fake","year":"1987","unstructured":"Fake CS, King FD, Sanger GJ (1987) BRL 43694: a potent and novel 5-HT3 receptor antagonist. Br J Pharmacol 91: 335","journal-title":"Br J Pharmacol"},{"key":"BF00689445_CR9","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1001\/jama.1981.03310290055028","volume":"245","author":"S Frytak","year":"1981","unstructured":"Frytak S, Moertel CG (1981) Management of nausea and vomiting in the cancer patient. JAMA 245: 393\u2013396","journal-title":"JAMA"},{"key":"BF00689445_CR10","first-page":"200","volume-title":"Principles of clinical electrocardiography","author":"MJ Goldman","year":"1976","unstructured":"Goldman MJ (1976) Normal cardiac rhythm and the atrial arrhythrias. In: Maruzen Asian (ed) Principles of clinical electrocardiography. 8th edn. Lange Medical Publications\/Maruzen, Tokyo, Japan, pp 200\u2013226","edition":"8th edn."},{"key":"BF00689445_CR11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1113\/expphysiol.1988.sp003124","volume":"73","author":"J Hawthorn","year":"1988","unstructured":"Hawthorn J, Osler KJ, Andrews PLR (1988) The role of the abdominal visceral innervation and 5-hydroxytryptamine M-receptors in vomiting induced by the cytotoxic drugs cyclophosphamide and cisplatin in the ferret. Q J Exp Physiol 73: 7\u201321","journal-title":"Q J Exp Physiol"},{"issue":"Suppl 1","key":"BF00689445_CR12","first-page":"S2","volume":"26","author":"RA Joss","year":"1990","unstructured":"Joss RA, Brand BC, Buser KS, Cerny T (1990) The symptomatic control of cytostatic drug-induced emesis. A recent history and review. Eur J Cancer 26 [Suppl 1]: S2-S8","journal-title":"Eur J Cancer"},{"key":"BF00689445_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1113\/jphysiol.1972.sp009784","volume":"222","author":"DL Kunze","year":"1972","unstructured":"Kunze DL (1972) Reflex discharge patterns of cardiac vagal efferent fibres. J Physiol (Lond) 222: 1\u201315","journal-title":"J Physiol (Lond)"},{"key":"BF00689445_CR14","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/0277-5379(91)90296-P","volume":"27","author":"J Lemerle","year":"1991","unstructured":"Lemerle J, Amaral D, Southall DP, Upward J, Murdoch RD (1991) Efficacy and safety of granisetron in the prevention of chemotherapy-induced emesis in paediatric patients. Eur J Cancer 27: 1081\u20131083","journal-title":"Eur J Cancer"},{"key":"BF00689445_CR15","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/0306-4522(90)90060-H","volume":"38","author":"RA Leslie","year":"1990","unstructured":"Leslie RA, Reynolds DJM, Andrews PLR, Grahame-Smith DG, Davis CJ Harvey JM (1990) Evidence for presynaptic 5-hydroxytryptamine3 recognition sites on vagal afferent terminals in the brainstem of the ferret. Neuroscience 38: 667\u2013673","journal-title":"Neuroscience"},{"issue":"Suppl 1","key":"BF00689445_CR16","first-page":"S28","volume":"26","author":"M Marty","year":"1990","unstructured":"Marty M, on behalf of the Granisetron Study Group (1990) A comparative study of the use of granisetron, a selective 5-HT3 antagonist, versus a standard anti-emetic regimen of chlorpromazine plus dexamethasone in the treatment of cytostatic-induced emesis. Eur J Cancer 26 [Suppl 1] S28-S32","journal-title":"Eur J Cancer"},{"issue":"Suppl 1","key":"BF00689445_CR17","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1016\/0959-8049(92)90630-K","volume":"28A","author":"M Marty","year":"1992","unstructured":"Marty M, on behalf on the Granisetron Study Group (1992) A comparison of granisetron as a single agent with conventional combination antiemetic therapies in the treatment of cytostatic-induced emesis. Eur J Cancer 28A [Suppl 1]: S12-S16","journal-title":"Eur J Cancer"},{"key":"BF00689445_CR18","first-page":"213","volume-title":"Harrison's principles of internal medicine","author":"AI Mendeloff","year":"1974","unstructured":"Mendeloff AI (1974) Constipation, diarrhea, and disturbances of anorectal function. In: Wintrobe MM, Thorn GW, Adams RD, Braunwald E, Isselbacher KJ Petersdorf RG. (eds) Harrison's principles of internal medicine, 7th edn. McGraw-Hill, New York, pp 213\u2013218","edition":"7th edn."},{"key":"BF00689445_CR19","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/0165-1838(90)90067-S","volume":"31","author":"S Milano","year":"1990","unstructured":"Milano S, Grelot L, Chen Z, Bianchi AL (1990) Vagal-induced vomiting in decerebrate cat is not suppressed by specific 5-HT3 receptor antagonists. J Auton Nerve Syst 31: 109\u2013118","journal-title":"J Auton Nerve Syst"},{"key":"BF00689445_CR20","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1016\/0006-2952(89)90319-5","volume":"38","author":"DR Nelson","year":"1989","unstructured":"Nelson DR, Thomas DR (1989) [3H]-BRL 43694 (graniseton), a specific ligand for 5-HT3 binding sites in rat brain cortical membranes. Biochem Pharmacol 38: 1693\u20131695","journal-title":"Biochem Pharmacol"},{"key":"BF00689445_CR21","doi-asserted-by":"publisher","first-page":"805","DOI":"10.2165\/00003495-199142050-00007","volume":"42","author":"GL Plosker","year":"1991","unstructured":"Plosker GL, Goa KL (1991) Granisetron: a review of its pharmacological properties and therapeutic use as an antiemetic. Drugs 42: 805\u2013824","journal-title":"Drugs"},{"key":"BF00689445_CR22","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1002\/1097-0142(19810501)47:9<2204::AID-CNCR2820470916>3.0.CO;2-A","volume":"47","author":"G Rosen","year":"1981","unstructured":"Rosen G, Caparros B, Nirenberg A, Marcove RC, Huvos AG, Kosloff C, Lane J, Murphy L (1981) Ewing's sarcoma: ten-year experience with adjuvant chemotherapy. Cancer 47: 2204\u20132213","journal-title":"Cancer"},{"key":"BF00689445_CR23","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1002\/1097-0142(19820315)49:6<1221::AID-CNCR2820490625>3.0.CO;2-E","volume":"49","author":"G Rosen","year":"1982","unstructured":"Rosen G, Caparros B, Huvos AG, Kosloff C, Nirenberg A, Cacavio A, Marcove RC, Lane JM, Mehta B, and Urban C (1982) Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer 49: 1221\u20131230","journal-title":"Cancer"},{"key":"BF00689445_CR24","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1161\/01.RES.44.1.75","volume":"44","author":"JF Spear","year":"1979","unstructured":"Spear JF, Kronhaus KD, Moore EN, Kline KP (1979) The effect of brief vagal stimulation on isolated rabbit sinus node. Circ Res 44: 75\u201388","journal-title":"Circ Res"},{"issue":"Suppl 1","key":"BF00689445_CR25","first-page":"S12","volume":"26","author":"JW Upward","year":"1990","unstructured":"Upward JW, Arnold BDC, Link C, Pierce DM, Allen A, Tasker TCG (1990) The clinical pharmacology of granisetron (BRL 43694), a novel specific 5-HT3 antagonist. Eur J Cancer 26 [Suppl 1]: S12-S15.","journal-title":"Eur J Cancer"},{"key":"BF00689445_CR26","first-page":"H935","volume":"257","author":"DW Wallick","year":"1989","unstructured":"Wallick DW, Martin PJ (1989) Brief vagal bursts can induce Wenckebach arrhythmia. Am J Physiol 257: H935-H941","journal-title":"Am J Physiol"},{"key":"BF00689445_CR27","first-page":"H523","volume":"243","author":"DW Wallick","year":"1982","unstructured":"Wallick DW, Martin PJ, Masuda Y, Levy MN (1982) Effects of autonomic activity and changes in heart rate on atrioventricular conduction. Am J Physiol 243: H523-H527","journal-title":"Am J Physiol"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00689445.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00689445\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00689445.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00689445","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T14:40:51Z","timestamp":1554820851000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00689445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,7]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1995,7]]}},"alternative-id":["BF00689445"],"URL":"https:\/\/doi.org\/10.1007\/bf00689445","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,7]]}}}